Plasma angiopoietin-1 is lower after ischemic stroke and associated with major disability but not stroke incidence

Stroke

Volumn 45, Issue 4, 2014, Pages 1064-1068

  Golledge, Jonathan ^a,b,f   Clancy, Paula ^a   Maguire, Jane ^c   Lincz, Lisa ^d,e   Koblar, Simon ^f   Mcevoy, Mark ^c,d   Attia, John ^c,d   Levi, Chris ^c   Sturm, Jonathan ^c,g   Almeida, Osvaldo P ^h   Yeap, Bu B ^i,k   Flicker, Leon ^j   Norman, Paul E ^h   Hankey, Graeme J ⁱ  

^a JAMES COOK UNIVERSITY   (Australia)

^b TOWNSVILLE HOSPITAL   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^e CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g Stroke Research Programme University of Adelaide Queen Elizabeth Hospital campus ^*  (Australia)

^h UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

ⁱ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^k FREMANTLE HOSPITAL   (Australia)

more..

Author keywords

Angiopoietin 1; Biological markers

Indexed keywords

ANGIOPOIETIN 1; CREATININE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

AGE; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CASE CONTROL STUDY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANKIN SCALE; RISK FACTOR; SEX DIFFERENCE; SMOKING; WAIST HIP RATIO;

ANGIOPOIETIN-1; BIOLOGICAL MARKERS;

AGED; ANGIOPOIETIN-1; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; DISABILITY EVALUATION; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84897412290     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.004339     Document Type: Article

References (19)

1. Golledge J, Siew DA. Identifying the carotid 'high risk' plaque: Is it still a riddle wrapped up in an enigma? Eur J Vasc Endovasc Surg. 2008;35:2-8.
2. Fukuhara S, Sako K, Noda K, Zhang J, Minami M, Mochizuki N. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol. 2010;25:387-396.
3. Hansen TM, Moss AJ, Brindle NP. Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke. Curr Neurovasc Res. 2008;5:236-245.
4. Zhang ZG, Zhang L, Croll SD, Chopp M. Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice. Neuroscience. 2002;113:683-687.
5. Shen F, Walker EJ, Jiang L, Degos V, Li J, Sun B, et al. Coexpression of angiopoietin-1 with VEGF increases the structural integrity of the blood-brain barrier and reduces atrophy volume. J Cereb Blood Flow Metab. 2011;31:2343-2351.
6. Cui X, Chopp M, Zacharek A, Ye X, Roberts C, Chen J. Angiopoietin/ Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke. Neurobiol Dis. 2011;43:285-292.
7. Zheng Q, Zhu D, Bai Y, Wu Y, Jia J, Hu Y. Exercise improves recovery after ischemic brain injury by inducing the expression of angiopoietin-1 and Tie-2 in rats. Tohoku J Exp Med. 2011;224:221-228.
8. Chen J, Yang T, Yu H, Sun K, Shi Y, Song W, et al. A functional variant in the 3'-UTR of angiopoietin-1 might reduce stroke risk by interfering with the binding efficiency of microRNA 211. Hum Mol Genet. 2010;19:2524-2533.
9. Maguire J, Thakkinstian A, Levi C, Lincz L, Bisset L, Sturm J, et al. Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: A novel finding. J Stroke. Cerebrovasc Dis. 2011;20:134-144.
10. World Health Organization Task Force. Recommendations on stroke prevention, diagnosis and therapy: Report of the WHO Task Force on Stroke and Other Cerebrovascular Disorders. Stroke. 1989;20:1407-1431.
11. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
12. McEvoy M, Smith W, D'Este C, Duke J, Peel R, Schofield P, et al. Cohort profile: The Hunter Community Study. Int J Epidemiol. 2010;39:1452-1463.
13. Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale. Stroke. 2007;38:e144, author reply e145.
14. Norman PE, Jamrozik K, Lawrence-Brown MM, Le MT, Spencer CA, Tuohy RJ, et al. Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ. 2004;329:1259.
15. Norman PE, Flicker L, Almeida OP, Hankey GJ, Hyde Z, Jamrozik K. Cohort Profile: The Health In Men Study (HIMS). Int J Epidemiol. 2009;38:48-52.
16. Golledge J, Clancy P, Jamrozik K, Norman PE. Obesity, adipokines, and abdominal aortic aneurysm: Health in Men study. Circulation. 2007;116:2275-2279.
17. Barr EL, Tonkin AM, Welborn TA, Shaw JE. Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: The AusDiab study. Intern Med J. 2009;39:49-53.
18. Golledge J, van Bockxmeer F, Jamrozik K, McCann M, Norman PE. Association between serum lipoproteins and abdominal aortic aneurysm. Am J Cardiol. 2010;105:1480-1484.
19. Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, et al. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab. 2002;22:379-392.